Recently I am researching about ACETYLCHOLINE-RELEASE ENHANCERS; LINOPIRDINE DUP 996; POTASSIUM CURRENTS; KCNQ; DRUG; MODULATORS; MECHANISM; AGENTS, Saw an article supported by the Marquette University [R01GM127513]; University of California funds; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) – USANIH National Institute of General Medical Sciences (NIGMS) [R01GM127513] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) – USA [S10OD021734] Funding Source: NIH RePORTER. Published in PERGAMON-ELSEVIER SCIENCE LTD in OXFORD ,Authors: Porter, JD; Vivas, O; Weaver, CD; Alsafran, A; DiMilo, E; Arnold, LA; Dickson, EJ; Dockendorff, C. The CAS is 90-44-8. Through research, I have a further understanding and discovery of Anthrone. Recommanded Product: 90-44-8
A set of novel Kv7.2/7.3 (KCNQ2/3) channel blockers was synthesized to address several liabilities of the known compounds XE991 (metabolic instability and CYP inhibition) and the clinical compound DMP 543 (acid instability, insolubility, and lipophilicity). Using the anthrone scaffold of the prior channel blockers, alternative heteroarylmethyl substituents were installed via enolate alkylation reactions. Incorporation of a pyridazine and a fluorinated pyridine gave an analog (compound 18, JDP-107) with a promising combination of potency (IC50=0.16 mu M in a Kv7.2 thallium flux assay), efficacy in a Kv7.2/7.3 patch clamp assay, and drug-like properties.
Welcome to talk about 90-44-8, If you have any questions, you can contact Porter, JD; Vivas, O; Weaver, CD; Alsafran, A; DiMilo, E; Arnold, LA; Dickson, EJ; Dockendorff, C or send Email.. Recommanded Product: 90-44-8
Reference:
Thiomorpholine – Wikipedia,
,Thiomorpholine | C4H9NS – PubChem